![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
ArisGlobal Extends Collaboration with Sitero for Drug Development Technology Platform
ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, and...
Introducing ReciPredict: Revolutionising Drug Product Development and Manufacturing
Recipharm announced the launch of ReciPredict, a cutting-edge platform for Quality by Design (QbD), designed...
Radiopharmaceuticals : Rapid Growth And Rising Investments
The radiopharmaceutical industry is growing very quickly. In the past few years, there have been...
GSKs Lung Cancer ADC Earns FDA Breakthrough Designation
The FDA has granted breakthrough status to an antibody-drug conjugate (ADC) that GSK licensed from...
Bayer And NextRNA Partner On New Small Molecule Cancer Drugs
Bayer and NextRNA Therapeutics, a biotechnology company, announced that they would be working together to...
Strategies To Improve Cell Line Development For Biologics
The capacity of a cell line to create a biologic that is both safe and...
Nuclear Medicine In North America: Market Growth & Trends
The North American nuclear medicine market was estimated to be worth USD 2.05 billion in...
Bayer & NextRNA Partner In $547Million Cancer Therapy Deal
This summer, Bayer officials made sure Fierce understood that the company's desire for deals hasn't...
New Endometrial Cancer Therapy Phase-II Trial Shows Promise
The most recent trial of a new antibody drug that goes on to deliver potent...
Duality Looks Out For Hong Kong IPO To Finance ADC Trials
Duality Biotherapeutics from China has gone ahead and filed paperwork as far as a Hong...